Association between epicardial adipose tissue and cardiac dysfunction in subjects with severe obesity

Aim Epicardial adipose tissue (EAT) plays a role in obesity‐related heart failure with preserved ejection fraction. However, the association of EAT thickness with the development of cardiac dysfunction in subjects with severe obesity without known cardiovascular disease is unclear. The aim of this s...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of heart failure Vol. 25; no. 11; pp. 1936 - 1943
Main Authors Chin, Jie Fen, Aga, Yaar S., Abou Kamar, S., Kroon, D., Snelder, Sanne M., Poll, Sweder W.E., Kardys, Isabella, Brugts, Jasper J., Boer, Rudolf A., Dalen, Bas M.
Format Journal Article
LanguageEnglish
Published Oxford, UK John Wiley & Sons, Ltd 01.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aim Epicardial adipose tissue (EAT) plays a role in obesity‐related heart failure with preserved ejection fraction. However, the association of EAT thickness with the development of cardiac dysfunction in subjects with severe obesity without known cardiovascular disease is unclear. The aim of this study was to determine the association between EAT thickness and cardiac dysfunction and describe the potential value of EAT as an early marker of cardiac dysfunction. Methods and results Subjects with body mass index ≥35 kg/m2 aged 35 to 65 years, who were referred for bariatric surgery, without suspicion of or known cardiac disease, were enrolled. Conventional transthoracic echocardiography and strain analyses were performed. A total of 186 subjects were divided into tertiles based on EAT thickness, of whom 62 were in EAT‐1 (EAT <3.8 mm), 63 in EAT‐2 (EAT 3.8–5.4 mm), and 61 in EAT‐3 (EAT >5.4 mm). Parameters of systolic and diastolic function were comparable between tertiles. Patients in EAT‐3 had the lowest global longitudinal strain (GLS) and left atrial contractile strain (LASct). Linear regression showed that a one‐unit increase in EAT thickness (mm) was independently associated with a decrease in GLS (%) (β coefficient −0.404, p = 0.002), and a decrease in LASct (%) (β coefficient −0.544, p = 0.027). Furthermore, EAT‐3 independently predicted cardiac dysfunction as defined by a GLS <18% (odds ratio 2.8, p = 0.013) and LASct <14% (odds ratio 2.5, p = 0.045). Conclusions Increased EAT thickness in subjects with obesity without known cardiac disease was independently associated with subclinical cardiac dysfunction. Our findings suggest that EAT might play a role in the early stages of cardiac dysfunction in obesity before this may progress to overt clinical disease. Association between epicardial adipose tissue (EAT) and cardiac dysfunction in severe obesity. BMI, body mass index; GLS, global longitudinal strain; LASct, left atrial contractile strain.
AbstractList Epicardial adipose tissue (EAT) plays a role in obesity-related heart failure with preserved ejection fraction. However, the association of EAT thickness with the development of cardiac dysfunction in subjects with severe obesity without known cardiovascular disease is unclear. The aim of this study was to determine the association between EAT thickness and cardiac dysfunction and describe the potential value of EAT as an early marker of cardiac dysfunction. Subjects with body mass index ≥35 kg/m aged 35 to 65 years, who were referred for bariatric surgery, without suspicion of or known cardiac disease, were enrolled. Conventional transthoracic echocardiography and strain analyses were performed. A total of 186 subjects were divided into tertiles based on EAT thickness, of whom 62 were in EAT-1 (EAT <3.8 mm), 63 in EAT-2 (EAT 3.8-5.4 mm), and 61 in EAT-3 (EAT >5.4 mm). Parameters of systolic and diastolic function were comparable between tertiles. Patients in EAT-3 had the lowest global longitudinal strain (GLS) and left atrial contractile strain (LASct). Linear regression showed that a one-unit increase in EAT thickness (mm) was independently associated with a decrease in GLS (%) (β coefficient -0.404, p = 0.002), and a decrease in LASct (%) (β coefficient -0.544, p = 0.027). Furthermore, EAT-3 independently predicted cardiac dysfunction as defined by a GLS <18% (odds ratio 2.8, p = 0.013) and LASct <14% (odds ratio 2.5, p = 0.045). Increased EAT thickness in subjects with obesity without known cardiac disease was independently associated with subclinical cardiac dysfunction. Our findings suggest that EAT might play a role in the early stages of cardiac dysfunction in obesity before this may progress to overt clinical disease.
Aim Epicardial adipose tissue (EAT) plays a role in obesity‐related heart failure with preserved ejection fraction. However, the association of EAT thickness with the development of cardiac dysfunction in subjects with severe obesity without known cardiovascular disease is unclear. The aim of this study was to determine the association between EAT thickness and cardiac dysfunction and describe the potential value of EAT as an early marker of cardiac dysfunction. Methods and results Subjects with body mass index ≥35 kg/m2 aged 35 to 65 years, who were referred for bariatric surgery, without suspicion of or known cardiac disease, were enrolled. Conventional transthoracic echocardiography and strain analyses were performed. A total of 186 subjects were divided into tertiles based on EAT thickness, of whom 62 were in EAT‐1 (EAT <3.8 mm), 63 in EAT‐2 (EAT 3.8–5.4 mm), and 61 in EAT‐3 (EAT >5.4 mm). Parameters of systolic and diastolic function were comparable between tertiles. Patients in EAT‐3 had the lowest global longitudinal strain (GLS) and left atrial contractile strain (LASct). Linear regression showed that a one‐unit increase in EAT thickness (mm) was independently associated with a decrease in GLS (%) (β coefficient −0.404, p = 0.002), and a decrease in LASct (%) (β coefficient −0.544, p = 0.027). Furthermore, EAT‐3 independently predicted cardiac dysfunction as defined by a GLS <18% (odds ratio 2.8, p = 0.013) and LASct <14% (odds ratio 2.5, p = 0.045). Conclusions Increased EAT thickness in subjects with obesity without known cardiac disease was independently associated with subclinical cardiac dysfunction. Our findings suggest that EAT might play a role in the early stages of cardiac dysfunction in obesity before this may progress to overt clinical disease. Association between epicardial adipose tissue (EAT) and cardiac dysfunction in severe obesity. BMI, body mass index; GLS, global longitudinal strain; LASct, left atrial contractile strain.
Epicardial adipose tissue (EAT) plays a role in obesity-related heart failure with preserved ejection fraction. However, the association of EAT thickness with the development of cardiac dysfunction in subjects with severe obesity without known cardiovascular disease is unclear. The aim of this study was to determine the association between EAT thickness and cardiac dysfunction and describe the potential value of EAT as an early marker of cardiac dysfunction.AIMEpicardial adipose tissue (EAT) plays a role in obesity-related heart failure with preserved ejection fraction. However, the association of EAT thickness with the development of cardiac dysfunction in subjects with severe obesity without known cardiovascular disease is unclear. The aim of this study was to determine the association between EAT thickness and cardiac dysfunction and describe the potential value of EAT as an early marker of cardiac dysfunction.Subjects with body mass index ≥35 kg/m2 aged 35 to 65 years, who were referred for bariatric surgery, without suspicion of or known cardiac disease, were enrolled. Conventional transthoracic echocardiography and strain analyses were performed. A total of 186 subjects were divided into tertiles based on EAT thickness, of whom 62 were in EAT-1 (EAT <3.8 mm), 63 in EAT-2 (EAT 3.8-5.4 mm), and 61 in EAT-3 (EAT >5.4 mm). Parameters of systolic and diastolic function were comparable between tertiles. Patients in EAT-3 had the lowest global longitudinal strain (GLS) and left atrial contractile strain (LASct). Linear regression showed that a one-unit increase in EAT thickness (mm) was independently associated with a decrease in GLS (%) (β coefficient -0.404, p = 0.002), and a decrease in LASct (%) (β coefficient -0.544, p = 0.027). Furthermore, EAT-3 independently predicted cardiac dysfunction as defined by a GLS <18% (odds ratio 2.8, p = 0.013) and LASct <14% (odds ratio 2.5, p = 0.045).METHODS AND RESULTSSubjects with body mass index ≥35 kg/m2 aged 35 to 65 years, who were referred for bariatric surgery, without suspicion of or known cardiac disease, were enrolled. Conventional transthoracic echocardiography and strain analyses were performed. A total of 186 subjects were divided into tertiles based on EAT thickness, of whom 62 were in EAT-1 (EAT <3.8 mm), 63 in EAT-2 (EAT 3.8-5.4 mm), and 61 in EAT-3 (EAT >5.4 mm). Parameters of systolic and diastolic function were comparable between tertiles. Patients in EAT-3 had the lowest global longitudinal strain (GLS) and left atrial contractile strain (LASct). Linear regression showed that a one-unit increase in EAT thickness (mm) was independently associated with a decrease in GLS (%) (β coefficient -0.404, p = 0.002), and a decrease in LASct (%) (β coefficient -0.544, p = 0.027). Furthermore, EAT-3 independently predicted cardiac dysfunction as defined by a GLS <18% (odds ratio 2.8, p = 0.013) and LASct <14% (odds ratio 2.5, p = 0.045).Increased EAT thickness in subjects with obesity without known cardiac disease was independently associated with subclinical cardiac dysfunction. Our findings suggest that EAT might play a role in the early stages of cardiac dysfunction in obesity before this may progress to overt clinical disease.CONCLUSIONSIncreased EAT thickness in subjects with obesity without known cardiac disease was independently associated with subclinical cardiac dysfunction. Our findings suggest that EAT might play a role in the early stages of cardiac dysfunction in obesity before this may progress to overt clinical disease.
Author Kardys, Isabella
Boer, Rudolf A.
Chin, Jie Fen
Aga, Yaar S.
Abou Kamar, S.
Poll, Sweder W.E.
Snelder, Sanne M.
Kroon, D.
Dalen, Bas M.
Brugts, Jasper J.
Author_xml – sequence: 1
  givenname: Jie Fen
  surname: Chin
  fullname: Chin, Jie Fen
  organization: Franciscus Gasthuis & Vlietland
– sequence: 2
  givenname: Yaar S.
  surname: Aga
  fullname: Aga, Yaar S.
  organization: Franciscus Gasthuis & Vlietland
– sequence: 3
  givenname: S.
  surname: Abou Kamar
  fullname: Abou Kamar, S.
  organization: Franciscus Gasthuis & Vlietland
– sequence: 4
  givenname: D.
  surname: Kroon
  fullname: Kroon, D.
  organization: Franciscus Gasthuis & Vlietland
– sequence: 5
  givenname: Sanne M.
  surname: Snelder
  fullname: Snelder, Sanne M.
  organization: Franciscus Gasthuis & Vlietland
– sequence: 6
  givenname: Sweder W.E.
  surname: Poll
  fullname: Poll, Sweder W.E.
  organization: Franciscus Gasthuis & Vlietland
– sequence: 7
  givenname: Isabella
  surname: Kardys
  fullname: Kardys, Isabella
  organization: Erasmus University Medical Center
– sequence: 8
  givenname: Jasper J.
  surname: Brugts
  fullname: Brugts, Jasper J.
  organization: Erasmus University Medical Center
– sequence: 9
  givenname: Rudolf A.
  surname: Boer
  fullname: Boer, Rudolf A.
  organization: Erasmus University Medical Center
– sequence: 10
  givenname: Bas M.
  surname: Dalen
  fullname: Dalen, Bas M.
  email: b.vandalen@franciscus.nl
  organization: Franciscus Gasthuis & Vlietland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37642195$$D View this record in MEDLINE/PubMed
BookMark eNp9kD1PwzAQhi0E4nvgDyCPMITaTuw4Y1W1fKgSC8yRY1-EqzQJOYcq_560BQYkmO5O97zv8JyRw7qpgZArzu44Y2ICq7fyLmacH5BTrtMsYjpJDsc91jrKdCJOyBniijGejvgxOYlTlQieyVMCU8TGehN8U9MCwgagptB6azrnTUWN822DQINH7IGa2tH9y1I3YNnXdpf0NcW-WIENSDc-vFGED-iANgWgD8MFOSpNhXD5Nc_J62L-MnuIls_3j7PpMrKxYjwqUqcKZUUphWBWCQlOy_EswWUgVSwVLwCEYcDjmEOZGKeUgTTNtJVOi_ic3Ox726557wFDvvZooapMDU2PudBSZzpNEzmi119oX6zB5W3n16Yb8m81I3C7B2zXIHZQ_iCc5Vvt-VZ7vtU-spNfrPVh5zR0xlf_JTa-guHv6nz-9LDYJT4BjoiVtw
CitedBy_id crossref_primary_10_1007_s10741_024_10438_2
crossref_primary_10_1038_s41572_024_00563_5
crossref_primary_10_1186_s12944_024_02266_y
crossref_primary_10_1016_j_diabres_2024_111878
crossref_primary_10_2174_0118715303310680240607114244
crossref_primary_10_1111_dom_16107
crossref_primary_10_1007_s11897_025_00700_5
crossref_primary_10_1016_j_ijcha_2024_101555
crossref_primary_10_1002_ejhf_3063
crossref_primary_10_1002_ejhf_3096
crossref_primary_10_1002_ejhf_3617
Cites_doi 10.1093/ehjci/jeaa091
10.1016/j.ejrad.2005.12.030
10.1136/bmjopen‐2018‐025585
10.1056/NEJMc1710026
10.1002/ehf2.13828
10.1002/clc.20837
10.1093/ehjci/jeaa415
10.1016/j.numecd.2019.08.007
10.1002/ejhf.1283
10.1002/ejhf.2513
10.1016/j.jchf.2020.04.016
10.1002/ehf2.12942
10.1016/S0140‐6736(11)60814‐3
10.1016/j.jcmg.2018.07.005
10.1016/j.jacc.2018.03.509
10.1002/ejhf.2337
10.1007/s10554‐022‐02744‐3
10.1093/cvr/cvac133
10.1093/ehjci/jeu184
10.1093/ehjci/jey042
10.1038/ncpcardio0319
10.1016/j.echo.2009.10.013
10.1007/s11695‐021‐05423‐9
10.1093/ehjci/jew082
10.1002/ejhf.2156
10.1038/s41569‐022‐00679‐9
10.1161/CIRCHEARTFAILURE.110.959890
10.1089/lap.2014.0639
10.1016/j.jchf.2018.05.018
10.1093/ehjci/jev014
10.1161/CIRCHEARTFAILURE.121.009238
10.1111/dom.14861
10.1016/j.jchf.2020.06.003
10.1161/CIRCULATIONAHA.116.026807
ContentType Journal Article
Copyright 2023 The Authors. published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
2023 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Copyright_xml – notice: 2023 The Authors. published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
– notice: 2023 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1002/ejhf.3011
DatabaseName Wiley Online Library Journals (Open Access)
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-0844
EndPage 1943
ExternalDocumentID 37642195
10_1002_ejhf_3011
EJHF3011
Genre researchArticle
Journal Article
GroupedDBID ---
--K
.I3
0R~
1B1
1OC
1~5
24P
29G
2WC
33P
4G.
53G
5GY
5VS
6PF
7-5
70D
AAESR
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAPNW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCUV
ABDBF
ABJNI
ABKDP
ABLJU
ABQWH
ABXGK
ABZBJ
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACRPL
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADEYI
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AENEX
AEQDE
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFWVQ
AGKEF
AHBTC
AIACR
AIJHB
AITYG
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
AVWKF
AZFZN
AZVAB
BDRZF
BFHJK
BHBCM
BMXJE
BRXPI
C45
CKLRP
CS3
CZ4
DCZOG
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBD
EBS
EJD
EMOBN
ESX
F5P
FEDTE
FUBAC
G-S
GODZA
H13
HGLYW
HVGLF
HZ~
IHE
IPNFZ
KBYEO
LATKE
LEEKS
LITHE
LOXES
LUTES
LYRES
M41
M49
MEWTI
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
N9A
NQ-
NU-
O0~
O66
O9-
OK1
OVD
O~Y
P2P
P2W
Q1.
RD5
RIG
ROL
RPZ
RXO
SDG
SEL
SEW
SUPJJ
SV3
TEORI
TUS
UHS
V9Y
W8F
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WVDHM
WXSBR
WYJ
X7H
~91
AAFWJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c3601-b7d6b6c2f5220c625ed85c2ffed9e563561bee2a0e1331ef4ad66ae7798c5d823
IEDL.DBID 24P
ISSN 1388-9842
1879-0844
IngestDate Fri Jul 11 01:58:30 EDT 2025
Mon Jul 21 06:06:33 EDT 2025
Tue Jul 01 01:54:30 EDT 2025
Thu Apr 24 23:07:57 EDT 2025
Wed Jan 22 16:17:29 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Obesity
Echocardiography
Cardiac dysfunction
Strain analyses
Epicardial adipose tissue
Language English
License Attribution-NonCommercial
2023 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3601-b7d6b6c2f5220c625ed85c2ffed9e563561bee2a0e1331ef4ad66ae7798c5d823
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fejhf.3011
PMID 37642195
PQID 2858987745
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_2858987745
pubmed_primary_37642195
crossref_primary_10_1002_ejhf_3011
crossref_citationtrail_10_1002_ejhf_3011
wiley_primary_10_1002_ejhf_3011_EJHF3011
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2023
2023-11-00
20231101
PublicationDateYYYYMMDD 2023-11-01
PublicationDate_xml – month: 11
  year: 2023
  text: November 2023
PublicationDecade 2020
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: England
PublicationTitle European journal of heart failure
PublicationTitleAlternate Eur J Heart Fail
PublicationYear 2023
Publisher John Wiley & Sons, Ltd
Publisher_xml – name: John Wiley & Sons, Ltd
References 2010; 33
2009; 22
2011; 378
2015; 16
2021; 23
2023; 39
2006; 57
2022; 24
2011; 4
2016; 17
2017; 377
2017; 136
2018; 20
2020; 8
2018; 6
2020; 7
2018; 19
2018; 8
2015; 25
2021; 31
2023; 25
2020; 30
2022; 9
2022; 15
2018; 71
2005; 2
2020; 21
2023; 118
2018; 11
2022; 19
e_1_2_6_32_1
e_1_2_6_10_1
e_1_2_6_31_1
e_1_2_6_30_1
e_1_2_6_19_1
e_1_2_6_13_1
e_1_2_6_36_1
e_1_2_6_14_1
e_1_2_6_35_1
e_1_2_6_11_1
e_1_2_6_34_1
e_1_2_6_12_1
e_1_2_6_33_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_16_1
e_1_2_6_21_1
e_1_2_6_20_1
Woerden G (e_1_2_6_28_1) 2022; 15
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_25_1
e_1_2_6_24_1
e_1_2_6_3_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_22_1
e_1_2_6_29_1
e_1_2_6_27_1
e_1_2_6_26_1
37858312 - Eur J Heart Fail. 2023 Nov;25(11):1944-1946
References_xml – volume: 33
  start-page: 760
  year: 2010
  end-page: 764
  article-title: Obesity is an independent risk factor for heart failure: Zona Franca cohort study
  publication-title: Clin Cardiol
– volume: 9
  start-page: 953
  year: 2022
  end-page: 957
  article-title: The value of echocardiographic measurement of epicardial adipose tissue in heart failure patients
  publication-title: ESC Heart Fail
– volume: 19
  start-page: 591
  year: 2018
  end-page: 600
  article-title: Standardization of left atrial, right ventricular, and right atrial deformation imaging using two‐dimensional speckle tracking echocardiography: A consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging
  publication-title: Eur Heart J Cardiovasc Imaging
– volume: 136
  start-page: 6
  year: 2017
  end-page: 19
  article-title: Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction
  publication-title: Circulation
– volume: 8
  start-page: 667
  year: 2020
  end-page: 676
  article-title: Epicardial adipose tissue and invasive hemodynamics in heart failure with preserved ejection fraction
  publication-title: JACC Heart Fail
– volume: 118
  start-page: 3536
  year: 2023
  end-page: 3555
  article-title: Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: Implications for future interventions
  publication-title: Cardiovasc Res
– volume: 71
  start-page: 2360
  year: 2018
  end-page: 2372
  article-title: Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium
  publication-title: J Am Coll Cardiol
– volume: 20
  start-page: 1559
  year: 2018
  end-page: 1566
  article-title: Epicardial fat in heart failure patients with mid‐range and preserved ejection fraction
  publication-title: Eur J Heart Fail
– volume: 30
  start-page: 99
  year: 2020
  end-page: 105
  article-title: Validation of the echocardiographic assessment of epicardial adipose tissue thickness at the Rindfleisch fold for the prediction of coronary artery disease
  publication-title: Nutr Metab Cardiovasc Dis
– volume: 23
  start-page: 1858
  year: 2021
  end-page: 1871
  article-title: Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure
  publication-title: Eur J Heart Fail
– volume: 16
  start-page: 1
  year: 2015
  end-page: 11
  article-title: Definitions for a common standard for 2D speckle tracking echocardiography: Consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging
  publication-title: Eur Heart J Cardiovasc Imaging
– volume: 15
  year: 2022
  article-title: Epicardial adipose tissue and outcome in heart failure with mid‐range and preserved ejection fraction
  publication-title: Circ Heart Fail
– volume: 11
  start-page: 1196
  year: 2018
  end-page: 1201
  article-title: Research to practice: Assessment of left ventricular global longitudinal strain for surveillance of cancer chemotherapeutic‐related cardiac dysfunction
  publication-title: JACC Cardiovasc Imaging
– volume: 24
  start-page: 1346
  year: 2022
  end-page: 1356
  article-title: Epicardial adipose tissue related to left atrial and ventricular function in heart failure with preserved versus reduced and mildly reduced ejection fraction
  publication-title: Eur J Heart Fail
– volume: 377
  start-page: 1496
  year: 2017
  end-page: 1497
  article-title: Health effects of overweight and obesity in 195 countries
  publication-title: N Engl J Med
– volume: 21
  start-page: 715
  year: 2020
  end-page: 717
  article-title: How to do LA strain
  publication-title: Eur Heart J Cardiovasc Imaging
– volume: 57
  start-page: 417
  year: 2006
  end-page: 422
  article-title: Mapping epicardial fat with multi‐detector computed tomography to facilitate percutaneous transepicardial arrhythmia ablation
  publication-title: Eur J Radiol
– volume: 25
  start-page: 196
  year: 2015
  end-page: 201
  article-title: Benefits of bariatric surgery do not reach obese men
  publication-title: J Laparoendosc Adv Surg Tech A
– volume: 378
  start-page: 815
  year: 2011
  end-page: 825
  article-title: Health and economic burden of the projected obesity trends in the USA and the UK
  publication-title: Lancet
– volume: 19
  start-page: 593
  year: 2022
  end-page: 606
  article-title: Epicardial adipose tissue in contemporary cardiology
  publication-title: Nat Rev Cardiol
– volume: 2
  start-page: 536
  year: 2005
  end-page: 543
  article-title: Epicardial adipose tissue: Anatomic, biomolecular and clinical relationships with the heart
  publication-title: Nat Clin Pract Cardiovasc Med
– volume: 23
  start-page: 61
  year: 2021
  end-page: 70
  article-title: Determinants of left atrial reservoir and pump strain and use of atrial strain for evaluation of left ventricular filling pressure
  publication-title: Eur Heart J Cardiovasc Imaging
– volume: 22
  start-page: 1311
  year: 2009
  end-page: 1319
  article-title: Echocardiographic epicardial fat: A review of research and clinical applications
  publication-title: J Am Soc Echocardiogr
– volume: 8
  year: 2018
  article-title: Cross‐sectional and prospective follow‐up study to detect early signs of cardiac dysfunction in obesity: Protocol of the CARDIOBESE study
  publication-title: BMJ Open
– volume: 25
  start-page: 177
  year: 2023
  end-page: 188
  article-title: Epicardial adipose tissue thickness is associated with reduced peak oxygen consumption and systolic reserve in patients with type 2 diabetes and normal heart function
  publication-title: Diabetes Obes Metab
– volume: 7
  start-page: 3726
  year: 2020
  end-page: 3737
  article-title: Subclinical cardiac dysfunction in obesity patients is linked to autonomic dysfunction: Findings from the CARDIOBESE study
  publication-title: ESC Heart Fail
– volume: 6
  start-page: 701
  year: 2018
  end-page: 709
  article-title: The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF
  publication-title: JACC Heart Fail
– volume: 8
  start-page: 657
  year: 2020
  end-page: 666
  article-title: Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction
  publication-title: JACC Heart Fail
– volume: 23
  start-page: 835
  year: 2021
  end-page: 838
  article-title: Epicardial fat in heart failure with reduced versus preserved ejection fraction
  publication-title: Eur J Heart Fail
– volume: 39
  start-page: 471
  year: 2023
  end-page: 479
  article-title: Decreased left atrial function in obesity patients without known cardiovascular disease
  publication-title: Int J Cardiovasc Imaging
– volume: 31
  start-page: 4206
  year: 2021
  end-page: 4209
  article-title: Cardiac function normalizes 1 year after bariatric surgery in half of the obesity patients with subclinical cardiac dysfunction
  publication-title: Obes Surg
– volume: 4
  start-page: 324
  year: 2011
  end-page: 331
  article-title: Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: Results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I‐PRESERVE) trial
  publication-title: Circ Heart Fail
– volume: 16
  start-page: 233
  year: 2015
  end-page: 270
  article-title: Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
  publication-title: Eur Heart J Cardiovasc Imaging
– volume: 17
  start-page: 1321
  year: 2016
  end-page: 1360
  article-title: Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
  publication-title: Eur Heart J Cardiovasc Imaging
– ident: e_1_2_6_23_1
  doi: 10.1093/ehjci/jeaa091
– ident: e_1_2_6_32_1
  doi: 10.1016/j.ejrad.2005.12.030
– ident: e_1_2_6_18_1
  doi: 10.1136/bmjopen‐2018‐025585
– ident: e_1_2_6_3_1
  doi: 10.1056/NEJMc1710026
– ident: e_1_2_6_35_1
  doi: 10.1002/ehf2.13828
– ident: e_1_2_6_5_1
  doi: 10.1002/clc.20837
– ident: e_1_2_6_25_1
  doi: 10.1093/ehjci/jeaa415
– ident: e_1_2_6_34_1
  doi: 10.1016/j.numecd.2019.08.007
– ident: e_1_2_6_31_1
  doi: 10.1002/ejhf.1283
– ident: e_1_2_6_30_1
  doi: 10.1002/ejhf.2513
– ident: e_1_2_6_13_1
  doi: 10.1016/j.jchf.2020.04.016
– ident: e_1_2_6_16_1
  doi: 10.1002/ehf2.12942
– ident: e_1_2_6_4_1
  doi: 10.1016/S0140‐6736(11)60814‐3
– ident: e_1_2_6_26_1
  doi: 10.1016/j.jcmg.2018.07.005
– ident: e_1_2_6_10_1
  doi: 10.1016/j.jacc.2018.03.509
– ident: e_1_2_6_14_1
  doi: 10.1002/ejhf.2337
– ident: e_1_2_6_15_1
  doi: 10.1007/s10554‐022‐02744‐3
– ident: e_1_2_6_27_1
  doi: 10.1093/cvr/cvac133
– ident: e_1_2_6_22_1
  doi: 10.1093/ehjci/jeu184
– ident: e_1_2_6_24_1
  doi: 10.1093/ehjci/jey042
– ident: e_1_2_6_11_1
  doi: 10.1038/ncpcardio0319
– ident: e_1_2_6_21_1
  doi: 10.1016/j.echo.2009.10.013
– ident: e_1_2_6_17_1
  doi: 10.1007/s11695‐021‐05423‐9
– ident: e_1_2_6_20_1
  doi: 10.1093/ehjci/jew082
– ident: e_1_2_6_33_1
  doi: 10.1002/ejhf.2156
– ident: e_1_2_6_2_1
– ident: e_1_2_6_9_1
  doi: 10.1038/s41569‐022‐00679‐9
– ident: e_1_2_6_7_1
  doi: 10.1161/CIRCHEARTFAILURE.110.959890
– ident: e_1_2_6_36_1
  doi: 10.1089/lap.2014.0639
– ident: e_1_2_6_8_1
  doi: 10.1016/j.jchf.2018.05.018
– ident: e_1_2_6_19_1
  doi: 10.1093/ehjci/jev014
– volume: 15
  year: 2022
  ident: e_1_2_6_28_1
  article-title: Epicardial adipose tissue and outcome in heart failure with mid‐range and preserved ejection fraction
  publication-title: Circ Heart Fail
  doi: 10.1161/CIRCHEARTFAILURE.121.009238
– ident: e_1_2_6_29_1
  doi: 10.1111/dom.14861
– ident: e_1_2_6_12_1
  doi: 10.1016/j.jchf.2020.06.003
– ident: e_1_2_6_6_1
  doi: 10.1161/CIRCULATIONAHA.116.026807
– reference: 37858312 - Eur J Heart Fail. 2023 Nov;25(11):1944-1946
SSID ssj0017002
Score 2.4753077
Snippet Aim Epicardial adipose tissue (EAT) plays a role in obesity‐related heart failure with preserved ejection fraction. However, the association of EAT thickness...
Epicardial adipose tissue (EAT) plays a role in obesity-related heart failure with preserved ejection fraction. However, the association of EAT thickness with...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1936
SubjectTerms Adipose Tissue - diagnostic imaging
Cardiac dysfunction
Echocardiography
Epicardial adipose tissue
Heart Failure
Humans
Obesity
Obesity - complications
Obesity, Morbid - complications
Pericardium - diagnostic imaging
Strain analyses
Title Association between epicardial adipose tissue and cardiac dysfunction in subjects with severe obesity
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fejhf.3011
https://www.ncbi.nlm.nih.gov/pubmed/37642195
https://www.proquest.com/docview/2858987745
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwEB5RkKpeKlr6WKDIrXrgkpL1xoktTtCyWiFRcQCJW-THWKVC2RXZPfTfMxNnQ1FbqbdEfhxmxp5vbM83AJ-N164YG5NVLkYKUIzLrIwyGwdN6Kgy3mrOHb74Xs6ui_MbdbMBx-tcmMQPMRy48cro9mte4Na1R4-kofjzR_zC5vkMtji1lt_zyeJyuEKo8vTgcEKmYHQh17RCuTwahj51Rn8gzKeAtfM402142UNFcZJ0-wo2sHkNzy_6y_AdwN9EK_r3VgIXJHVW-p2w4XYxb1EsO9kK2wSRmrwIv1p2aN3I20a0K8fHMa3gU1lBvhLvUcxTyYA3cD09u_o6y_qqCZmfUHSVuSqUrvQyErLKPYU3GLSi34jBoGI6urFDlDZHCk_HGAsbytJiVRntVdBy8hY2m3mD70HoHJVTRQh2QlGTj1bFKienKtH4QlkzgsO1-GrfU4pzZYu7OpEhy5olXbOkR_Bp6LpIPBp_6_RxrYOarJyvLmyD81VbS6200QRV1QjeJeUM09AWWdC-Sy2Hnbb-PX99dj6b8sfu_3fdgxdcYT6lH-7D5vJ-hR8IhyzdQWdvB7B1cvrtdPoAZhDcaw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LT9wwEB5RKrVcUN8sUGqqHrikZL12YktcqorVlrKIA0jcIj_GKghlV2T3wL9nHGfTorYSt0R-HGbGnm_G9jcAX7RTVgy1zkobAgUo2maGB54NvSJ0VGpnVHw7PD0rJpfi5EpercHR6i1M4ofoE25xZbT7dVzgMSF9-Js1FG9-ha_RPp_Bc1HwMtYv4OK8P0Mo83TjcES2oJXgK16hnB_2Qx97o78g5mPE2rqc8SvY7LAi-5aU-xrWsH4DL6bdafhbwD9ky7oLVwznJPao9Vtm_PV81iBbtMJlpvYsNTnm75vo0dqR1zVrljbmYxoW07KMnCXeIZulmgHv4HJ8fPF9knVlEzI3ovAqs6UvbOF4IGiVO4pv0CtJvwG9Rhn56IYWkZscKT4dYhDGF4XBstTKSa_46D2s17Mat4CpHKWVwnszorDJBSNDmZNX5aidkEYP4GAlvsp1nOKxtMVtldiQeRUlXUVJD-Bz33WeiDT-1Wl_pYOKzDyeXZgaZ8um4koqrQirygF8SMrpp6E9UtDGSy0Hrbb-P391fDIZx4_tp3f9BC8nF9PT6vTH2c8d2Ijl5tNbxF1YX9wt8SOBkoXda23vAWC73mU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6VIlVcEOW5QMFUPfQSmvXGiS1OqO1qKbTqgUq9RX6MRVGVXTW7B_49M3E2bQVI3BL5cZgZe77x2N8A7BmvXTE2JqtcjBSgGJdZGWU2DprQUWW81fx2-PSsnF0UJ5fqcgM-rd_CJH6I4cCNV0a3X_MCX4R4cEsaij9_xI9sng_gISf7-D6XLM6HFEKVpwuHEzIFowu5phXK5cEw9L4z-gNh3gesnceZPoHHPVQUn5Nut2EDm6ewddonw58B3hGt6O9bCVyQ1Fnp18KGq8W8RbHsZCtsE0Rq8iL8atmhdSOvGtGuHB_HtIJPZQX5SrxBMU8lA57DxfT4--Es66smZH5C0VXmqlC60stIyCr3FN5g0Ip-IwaDiunoxg5R2hwpPB1jLGwoS4tVZbRXQcvJC9hs5g2-AqFzVE4VIdgJRU0-WhWrnJyqROMLZc0I9tfiq31PKc6VLa7rRIYsa5Z0zZIewe7QdZF4NP7W6cNaBzVZOacubIPzVVtLrbTRBFXVCF4m5QzT0BZZ0L5LLfudtv49f318Mpvyx-v_7_oets6PpvW3L2df38AjLjafXiK-hc3lzQp3CJIs3bvO9H4DNVbdlw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+epicardial+adipose+tissue+and+cardiac+dysfunction+in+subjects+with+severe+obesity&rft.jtitle=European+journal+of+heart+failure&rft.au=Chin%2C+Jie+Fen&rft.au=Aga%2C+Yaar+S&rft.au=Abou+Kamar%2C+S&rft.au=Kroon%2C+D&rft.date=2023-11-01&rft.issn=1879-0844&rft.eissn=1879-0844&rft.volume=25&rft.issue=11&rft.spage=1936&rft_id=info:doi/10.1002%2Fejhf.3011&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1388-9842&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1388-9842&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1388-9842&client=summon